Pennvax-B: Interim Phase I data

Interim data from the double-blind, placebo-controlled, U.S. Phase I HVTN-080 trial in 48 healthy volunteers showed that 26 of 31 evaluable subjects had positive T cell responses after 3 vaccinations ...